Multiple Assemblies exist for SMTL entry 4w9c
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(oxazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 2); X-RAY DIFFRACTION 2.20 Å

	SMTL ID 4w9c.1 Ligands (4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-[4-(1,3-oxazol-5-yl)benzyl]-L-prolinamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 4w9c.2 Ligands (4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-[4-(1,3-oxazol-5-yl)benzyl]-L-prolinamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 4w9c.3 Ligands (4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-[4-(1,3-oxazol-5-yl)benzyl]-L-prolinamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 4w9c.4 Ligands (4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-[4-(1,3-oxazol-5-yl)benzyl]-L-prolinamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer